Similar Articles

Home | Newsletter | My Articles | My Account | Help

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool January 5, 2006 Nathan Parmelee	Neogen Keeps Things Clean The food and animal testing company continues its slow but consistent growth. This is an attractively positioned business, but its shares sport a price tag that's just a bit too high.
The Motley Fool January 3, 2012 Seth Jayson	Neogen Increases Sales but Misses Revenue Estimate Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Neogen is outperform, with an average price target of $39.60.
The Motley Fool March 23, 2006 Nathan Parmelee	Neogen Still Looks Pricey The food-safety and animal-health product producer's income statement performance is impressive, but the shares are still a bit expensive. Investors, take note.
The Motley Fool March 28, 2005 Nathan Parmelee	Neogen Safe for Investors? The safety-products maker reported flat earnings, but it takes the blame and plans out a rebound. Investors, take note.